Novel Psychoactive Substances 2013
DOI: 10.1016/b978-0-12-415816-0.00007-9
|View full text |Cite
|
Sign up to set email alerts
|

Synthetic Amphetamine Derivatives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 57 publications
0
3
0
Order By: Relevance
“…2,5-Dimethoxy-4-iodoamphetamine (DOI) is a substituted amphetamine but is not a stimulant. It is a potent 5-HT 2 A serotonin receptor agonist and is used recreationally as a hallucinogenic drug ( Lapoint et al, 2013 ). DOI induces cutaneous vascular constriction in rabbits and rats, and this is the suggested cause of hyperthermia resulting from serotonin receptor stimulation ( Blessing and Seaman, 2003 ).…”
Section: Lsec and Drug Interactionsmentioning
confidence: 99%
“…2,5-Dimethoxy-4-iodoamphetamine (DOI) is a substituted amphetamine but is not a stimulant. It is a potent 5-HT 2 A serotonin receptor agonist and is used recreationally as a hallucinogenic drug ( Lapoint et al, 2013 ). DOI induces cutaneous vascular constriction in rabbits and rats, and this is the suggested cause of hyperthermia resulting from serotonin receptor stimulation ( Blessing and Seaman, 2003 ).…”
Section: Lsec and Drug Interactionsmentioning
confidence: 99%
“…(Rahman, Fazilah, & Effarizah, 2015), elemicin in food upto 0.05 mg/kg (De Vincenzi, De Vincenzi, & Silano, 2004) and 0.02–1.88 mg/L of DMT, 5‐MeO‐DMT, harmaline, tetrahydroharmine, harmine in cardiac blood (Sklerov, Levine, Moore, King, & Fowler, 2005). Myristicin of nutmeg oil is metabolized to the controlled drugs namely, MMDA, MDMA, MMDMA (Clark, DeRuiter, & Noggle, 1996), safrole to MDA (Shulgin, Sargent, & Naranjo, 1967), elemicin to 3,4,5‐Trimethoxyamphetamine (Lapoint, Dargan, & Hoffman, 2013), whereas 5‐MeO‐DMT, DMT were used as controlled substances in USA and UK (Federal Register, 2010; Tittarelli, Mannocchi, Pantano, & Saverio Romolo, 2015; Waller & Sampson, 2018).…”
Section: Poisoning and Toxicitymentioning
confidence: 99%
“…Thus, one may assume that the cases of severe toxicity reported after recreational use of these drugs (e.g. Elliott, 2000;De Letter et al, 2001;Martin, 2001;Lamberth et al, 2008), which resemble "serotonin syndrome" symptoms (Lapoint et al, 2013), are related to a sustained increase of synaptic 5-HT and DA resulting from both monoamine reverse transport and MAO-A inhibition. Furthermore, as many AMPH derivatives are monoamine transporter substrates (Simmler et al, 2013;Sitte and Freissmuth, 2015), even in those cases in which relatively weak MAOI activity is demonstrated, these drugs might be concentrated in presynaptic nerve terminals or glial cells, and some enzyme inhibition could occur (Heal et al, 2013).…”
Section: Summary Of Structure-activity Relationships and Implicationsmentioning
confidence: 99%